HIGHLIGHTS
- who: Likun Luan and colleagues from the University of Texas MD Anderson Cancer Center, United States have published the paper: Development of a novel hypoxia-immuneu2013related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer, in the Journal: (JOURNAL)
- what: The aim of this study was to identify lncRNAs closely related to hypoxia and immunity through the public resources of CRC patients from TCGA and Gene Expression Omnibus (GEO) databases, construct a hypoxia-immune-related lncRNA signature, and explore the potential value of the signature in the prognosis and immunotherapy sensitivity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.